The complete genome sequence of unculturable
Humans
Metagenomics
/ methods
Genome, Bacterial
High-Throughput Nucleotide Sequencing
Mycoplasma
/ genetics
Mycoplasma Infections
/ microbiology
Whole Genome Sequencing
/ methods
Lung Transplantation
Prophages
/ genetics
Interspersed Repetitive Sequences
/ genetics
Anti-Bacterial Agents
/ pharmacology
Mycoplasma faucium
ice
insertion sequence
lung transplant patient
metagenomics
Journal
Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359
Informations de publication
Date de publication:
2024
2024
Historique:
received:
11
01
2024
accepted:
25
03
2024
medline:
2
5
2024
pubmed:
2
5
2024
entrez:
2
5
2024
Statut:
epublish
Résumé
Diagnosing This study analyzes the complete genome sequence of Genome analysis revealed limited therapeutic options for the This study represents the first-ever acquisition of a complete circularized bacterial genome directly from a patient sample obtained from invasive infection of a primary sterile site using culture-independent, PCR-free clinical metagenomics.
Identifiants
pubmed: 38694516
doi: 10.3389/fcimb.2024.1368923
pmc: PMC11062135
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1368923Informations de copyright
Copyright © 2024 Sabat, Durfee, Baldwin, Akkerboom, Voss, Friedrich and Bathoorn.
Déclaration de conflit d'intérêts
Authors TD and SB are employees of the company DNASTAR, Inc. SB is a minor shareholder in DNASTAR, Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.